Antiviral strategies against human norovirus: Molecular targets, therapeutics, and vaccine development

Sadia Islam, Sabbir Alam Zia, Simonto Mirza, Md Moshiur Rahman, Md Abdullah All Shafi, Md Hamed Hasan, Abdullah Al Mamun, Department of Fishing and Post-Harvest Technology, Faculty of Fisheries, Chattogram Veterinary and Animal Sciences University, Department of Physiology, Faculty of Veterinary Medicine, Chattogram Veterinary and Animal Sciences University, Department of Physical and Mathematical Sciences, Faculty of Food Science and Technology, Chattogram Veterinary and Animal Sciences University, Department of Medicine and Surgery, Faculty of Veterinary Medicine, Chattogram Veterinary and Animal Sciences University, Department of Microbiology and Veterinary Public Health, Faculty of Veterinary Medicine, Chattogram Veterinary and Animal Sciences University, Department of Biotechnology and Genetic Engineering, Faculty of Biological Science, Islamic University

Therapeutic Advances in Infectious Disease

Published online on August 13, 2026

Abstract

Therapeutic Advances in Infectious Disease, Volume 13, January-December 2026.
Human norovirus (HuNoV) is a leading cause of acute viral gastroenteritis worldwide and represents a major unmet challenge in antiviral drug and vaccine development. HuNoV is a non-enveloped, positive-sense RNA virus characterized by extensive genetic ...